- Home
- MYND vs ANEB Comparison
MYND vs ANEB Comparison
Compare MYND & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYND
- ANEB
- Stock Information
- Founded
- MYND 1998
- ANEB 2020
- Country
- MYND United States
- ANEB United States
- Employees
- MYND N/A
- ANEB N/A
- Industry
- MYND Other Consumer Services
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- MYND Real Estate
- ANEB Health Care
- Exchange
- MYND Nasdaq
- ANEB Nasdaq
- Market Cap
- MYND 38.8M
- ANEB 39.0M
- IPO Year
- MYND 2017
- ANEB 2021
- Fundamental
- Price
- MYND $0.83
- ANEB $0.98
- Analyst Decision
- MYND
- ANEB Buy
- Analyst Count
- MYND 0
- ANEB 1
- Target Price
- MYND N/A
- ANEB $8.00
- AVG Volume (30 Days)
- MYND 46.1K
- ANEB 10.6K
- Earning Date
- MYND 05-20-2025
- ANEB 05-13-2025
- Dividend Yield
- MYND N/A
- ANEB N/A
- EPS Growth
- MYND N/A
- ANEB N/A
- EPS
- MYND N/A
- ANEB N/A
- Revenue
- MYND $267,380,999.00
- ANEB N/A
- Revenue This Year
- MYND N/A
- ANEB N/A
- Revenue Next Year
- MYND N/A
- ANEB N/A
- P/E Ratio
- MYND N/A
- ANEB N/A
- Revenue Growth
- MYND N/A
- ANEB N/A
- 52 Week Low
- MYND $0.61
- ANEB $0.80
- 52 Week High
- MYND $3.89
- ANEB $3.18
- Technical
- Relative Strength Index (RSI)
- MYND 52.30
- ANEB 37.61
- Support Level
- MYND $0.74
- ANEB $0.97
- Resistance Level
- MYND $0.92
- ANEB $1.30
- Average True Range (ATR)
- MYND 0.09
- ANEB 0.10
- MACD
- MYND 0.02
- ANEB -0.01
- Stochastic Oscillator
- MYND 46.43
- ANEB 3.03
About MYND Mynd.ai Inc.
Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.